Back to Search
JOHN MACIEJEWSKI, M.D.
M.D.
Hematology (Internal Medicine) Physician
NPI: 1235334137IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
4301116418(MI)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
036-109957(IL)4301116418(MI)
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
036-109957(IL)
Education
R FRANKLIN UNIVERSITY OF MED & SCI/CHICAGO MEDICAL SCHOOL
Class of 2001
Research & Publications (20)
Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.
PMID 19372255·Blood·2009
4-observational
Clinical and morphological aspects of thin glomerular basement membrane disease.
PMID 19670702·Pol J Pathol·2009
8-other
Clonotype analysis of cytomegalovirus-specific cytotoxic T lymphocytes.
PMID 18799721·J Am Soc Nephrol·2009
8-other
A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide.
PMID 19470455·Proc Natl Acad Sci U S A·2009
8-other
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.
PMID 18832655·Blood·2009
8-other
Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies.
PMID 19563474·Br J Haematol·2009
6-review
Diagnosis and therapy of neutropenia in large granular lymphocyte leukemia.
PMID 19057202·Curr Opin Hematol·2009
6-review
UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation.
PMID 18818701·Leukemia·2009
8-other
Relationship of treatment-related cytopenias and response to lenalidomide in patients with lower-risk myelodysplastic syndromes.
PMID 19018091·J Clin Oncol·2008
3-trial
Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative disorders with JAK2 V617F.
PMID 18479730·Hum Pathol·2008
5-case
Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys.
PMID 18957672·J Natl Cancer Inst·2008
8-other
Prevalence of latent tuberculosis infection in health care workers in Poland assessed by interferon-gamma whole blood and tuberculin skin tests.
PMID 19218645·J Physiol Pharmacol·2008
8-other
Altered lipid raft composition and defective cell death signal transduction in glycosylphosphatidylinositol anchor-deficient PIG-A mutant cells.
PMID 18544084·Br J Haematol·2008
8-other
Whole genome scanning as a cytogenetic tool in hematologic malignancies.
PMID 18505780·Blood·2008
6-review
Regulation of IL-2 expression by transcription factor BACH2 in umbilical cord blood CD4+ T cells.
PMID 18769450·Leukemia·2008
8-other
Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia.
PMID 18550263·Exp Hematol·2008
4-observational
Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing.
PMID 19027491·Cancer Genet Cytogenet·2008
8-other
250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.
PMID 19074904·Cancer Res·2008
8-other
Titanocene(III)-catalyzed formation of indolines and azaindolines.
PMID 18781767·Org Lett·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 E MEDICAL CENTER DR
ANN ARBOR, MI 48109 - Phone
- (734) 936-4000
Quick Facts
- NPI
- 1235334137
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 25
- Publications
- 20
Are you this provider?
Claim Your Profile